CRO concept sector surges, Ruizhi Pharmaceutical hits the daily limit

MaticHoleFiller · 2026-04-03T00:02:40+00:00

April 1st news, the CRO concept sector rose significantly, with several stocks such as Ruizhi Medicine and Kelaiying hitting the daily limit, and market activity was lively. Investors are reminded to be cautious of risks; information is for reference only.

MaticHoleFiller

2026-04-03 00:02:40

Abstract generation in progress

April 1 news, as of 14:21, the CRO concept sector surged, with Zhishi Pharmaceutical and Kailaiying hitting the daily limit. Chengda Pharmaceutical, Heta Bio, Kanglong Chemical, Boteng Co., Ltd., Lingkang Pharmaceutical (rights protection), Tigermed, WuXi AppTec, Wanbang Pharmaceutical, and other stocks led the gains.

Statement: The market is risky, and investment requires caution. This article is automatically published based on third-party databases and does not represent Sina Finance’s views. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are discrepancies, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

A wealth of information and precise analysis—available in the Sina Finance app

Editor: Xiaolang Express

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.